These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8511923)

  • 1. Neoadjuvant chemotherapy for high-grade advanced gastric cancer.
    Yonemura Y; Sawa T; Kinoshita K; Matsuki N; Fushida S; Tanaka S; Ohoyama S; Takashima T; Kimura H; Kamata T
    World J Surg; 1993; 17(2):256-61; discussion 261-2. PubMed ID: 8511923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
    Kato M; Kinoshita K; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Segawa M; Ohyama S; Yonemura Y; Miwa K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):391-6. PubMed ID: 2106835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
    Hasegawa Y; Honnma S; Takanashi K; Yajima K; Nakashima Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):2047-51. PubMed ID: 1908669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
    Matsumoto H; Yonemura Y; Kosaka T; Muraoka K; Kaji M; Nakai M; Tsugawa K; Segawa M; Fushida S; Takano Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2227-30. PubMed ID: 1444489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
    Sawa T; Kinoshita K; Takekawa S; Ohyama S; Hasegawa K; Fujimura T; Ueda N; Watanabe T; Kato M; Miyata T
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2381-6. PubMed ID: 2260875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
    Yonemura Y; Kinoshita K; Fujimura T; Fushida S; Sawa T; Matsuki N; Tanaka S; Kamata T; Takashima T; Miyazaki I
    Hepatogastroenterology; 1996; 43(11):1260-72. PubMed ID: 8908561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
    Kinoshita K; Kato M; Sawa T; Yoshimitsu S; Tomita F; Takano Y; Yonemura Y; Miyazaki I; Matsui H
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):651-5. PubMed ID: 8470925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
    Nakajima T; Nashimoto A; Kitamura M; Kito T; Iwanaga T; Okabayashi K; Goto M
    Lancet; 1999 Jul; 354(9175):273-7. PubMed ID: 10440302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
    Fushida S; Minatoya T; Hayashi T; Ajisaka H; Bando E; Taniguchi K; Fujimura T; Nishimura G; Yonemura Y; Miwa K
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):271-5. PubMed ID: 10700899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study.
    Gallardo-Rincón D; Oñate-Ocaña LF; Calderillo-Ruiz G
    Ann Surg Oncol; 2000; 7(1):45-50. PubMed ID: 10674448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
    Yabushita K; Konishi K; Kuroda Y; Fukushima W; Sahara H; Saitoh F; Kadoya N; Taniya T; Hirosawa H; Tsuji M
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2231-4. PubMed ID: 1444490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
    Ueda N; Yoshimitsu Y; Ohta N; Kadoya N; Hirosawa H; Konishi I; Izumi R; Hirono T; Saito K
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1833-6. PubMed ID: 8937494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
    Konishi K; Yabushita K; Tsugawa K; Kuroda Y; Tsuji M; Demachi H
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1969-72. PubMed ID: 7487128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
    Shinoda M; Morise K; Kusugami K; Iwase H; Ina K; Kaneko H; Horiuchi Y; Kuroiwa A; Suga S; Oka Y
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):515-20. PubMed ID: 7887643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer.
    Kochi M; Fujii M; Kanamori N; Kaiga T; Takahashi T; Kobayashi M; Takayama T
    J Cancer Res Clin Oncol; 2006 Dec; 132(12):781-5. PubMed ID: 16804723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer--(Part 2). Comparisons between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Kuroda Y; Arima S; Ohsato K; Ohkuma R; Fukuyama N; Yamanouchi A; Hisatsugu T; Yamamoto H; Nakamura Y; Abe R
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2235-40. PubMed ID: 2500069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
    Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
    Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
    Yabusaki H; Nashimoto A; Tanaka O
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.